Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of SBIR/STTR awards granted to SPR Therapeutics

List of SBIR/STTR awards granted to SPR Therapeutics

List of SBIR/STTR awards granted to BELTRAN, INC.

List of SBIR/STTR awards granted to Control Vision, Inc.

List of SBIR/STTR awards granted to KENT OPTRONICS INC

List of companies in Sam Parr (entrepreneur)'s investment portfolio

List of deodorant patents

where

SBIR/STTR Award Recipient

is

SPR Therapeutics

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ SPR THERAPEUTICS, INC. SBIR Phase II Award, September 2021	A SBIR Phase II contract was awarded to SPR Therapeutics in September, 2021 for $954,397.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	SPR Therapeutics		National Institutes of Health	SBIR	2R44AG052196-04A1	Phase II	954,397	September 30, 2021	sbir.gov/node/2190151
	‌ SPR THERAPEUTICS, INC. SBIR Phase II Award, September 2018	A SBIR Phase II contract was awarded to SPR Therapeutics in September, 2018 for $980,968.0 USD from the U.S. Department of Defense and Defense Health Agency.	SPR Therapeutics	U.S. Department of Defense	Defense Health Agency	SBIR	W81XWH18C0329	Phase II	980,968	September 24, 2018	sbir.gov/node/1592879
	‌ SPR THERAPEUTICS, INC. SBIR Phase I Award, August 2015	A SBIR Phase I contract was awarded to SPR Therapeutics in August, 2015 for $209,948.0 USD from the U.S. Department of Health & Human Services.	SPR Therapeutics			SBIR	1R44AG052196-01	Phase I	209,948	August 15, 2015	sbir.gov/node/1046301
	‌ SPR THERAPEUTICS, INC. SBIR Phase II Award, March 2017	A SBIR Phase II contract was awarded to SPR Therapeutics in March, 2017 for $2,995,755.0 USD from the U.S. Department of Health & Human Services.	SPR Therapeutics			SBIR	2SB1NS066523-05	Phase II	2,995,755	March 15, 2017	sbir.gov/node/1247797
	‌ SPR THERAPEUTICS, INC. SBIR Phase II Award, March 2015	A SBIR Phase II contract was awarded to SPR Therapeutics in March, 2015 for $1,456,887.0 USD from the U.S. Department of Health & Human Services.	SPR Therapeutics			SBIR	2R44NS066523-03	Phase II	1,456,887	March 1, 2015	sbir.gov/node/1048367
	‌ SPR THERAPEUTICS, INC. SBIR Phase II Award, June 2016	A SBIR Phase II contract was awarded to SPR Therapeutics in June, 2016 for $1,721,202.0 USD from the U.S. Department of Health & Human Services.	SPR Therapeutics			SBIR	4R44AG052196-02	Phase II	1,721,202	June 1, 2016	sbir.gov/node/1164793
	‌ SPR THERAPEUTICS, INC. SBIR Phase II Award, May 2014	A SBIR Phase II contract was awarded to SPR Therapeutics in May, 2014 for $2,910,896.0 USD from the U.S. Department of Health & Human Services.	SPR Therapeutics			SBIR	2R44HD067094-04	Phase II	2,910,896	May 1, 2014	sbir.gov/node/1032127
	‌ SPR THERAPEUTICS, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to SPR Therapeutics for $2,910,896.0 USD from the U.S. Department of Health & Human Services.	SPR Therapeutics			SBIR	2R44HD067094-04	Phase II	2,910,896		sbir.gov/node/710177

8 results

0 selected

8 results

0 selected